Logo video2dn
  • Сохранить видео с ютуба
  • Категории
    • Музыка
    • Кино и Анимация
    • Автомобили
    • Животные
    • Спорт
    • Путешествия
    • Игры
    • Люди и Блоги
    • Юмор
    • Развлечения
    • Новости и Политика
    • Howto и Стиль
    • Diy своими руками
    • Образование
    • Наука и Технологии
    • Некоммерческие Организации
  • О сайте

Скачать или смотреть “The Buzz'' Show: BeyondSpring (NASDAQ: BYSI) Results from its DUBLIN-3 Registrational Trial

  • FinancialBuzz TV
  • 2021-08-04
  • 6
“The Buzz'' Show: BeyondSpring (NASDAQ: BYSI) Results from its DUBLIN-3 Registrational Trial
Financial NewsBusiness NewsFinanceStock Market NewsInvestment NewsClinicalTrialPositiveResultsMedicinePlinabulinDocetaxelStudyPatientsMedicalNeedschemotherapy
  • ok logo

Скачать “The Buzz'' Show: BeyondSpring (NASDAQ: BYSI) Results from its DUBLIN-3 Registrational Trial бесплатно в качестве 4к (2к / 1080p)

У нас вы можете скачать бесплатно “The Buzz'' Show: BeyondSpring (NASDAQ: BYSI) Results from its DUBLIN-3 Registrational Trial или посмотреть видео с ютуба в максимальном доступном качестве.

Для скачивания выберите вариант из формы ниже:

  • Информация по загрузке:

Cкачать музыку “The Buzz'' Show: BeyondSpring (NASDAQ: BYSI) Results from its DUBLIN-3 Registrational Trial бесплатно в формате MP3:

Если иконки загрузки не отобразились, ПОЖАЛУЙСТА, НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если у вас возникли трудности с загрузкой, пожалуйста, свяжитесь с нами по контактам, указанным в нижней части страницы.
Спасибо за использование сервиса video2dn.com

Описание к видео “The Buzz'' Show: BeyondSpring (NASDAQ: BYSI) Results from its DUBLIN-3 Registrational Trial

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “BeyondSpring Surged 191% Following Positive Topline Results from its DUBLIN-3 Registrational Trial”

“The Buzz'' Show: BeyondsSpring Inc. Surged 191% Following Positive Topline Results from its DUBLIN-3 Registrational Trial

Beyondspring (NASDAQ: BYSI) skyrocketed over 191% in premarket trading after the company announced the positive topline data from the DUBLIN-3 registrational trial.

The study met primary and secondary endpoints, showing statistically significant improvement in overall survival and statistically significant improvement for the combination of plinabulin with docetaxel against docetaxel alone in ORR, PFS, and 24- and 36-month OS rates.

Headquartered in New York City, BeyondSpring is a global biopharmaceutical company focused on developing innovative cancer therapies to improve clinical outcomes for patients who have high unmet medical needs. BeyondSpring’s first-in-class lead asset plinabulin, is being developed as a “pipeline in a drug.” It is filed for approval and has received Priority Review in the U.S. and China for the prevention of chemotherapy-induced neutropenia (CIN) with a PDUFA date of November 30, 2021 in the U.S., and has a fully enrolled pivotal study (DUBLIN-3) to test an anti-cancer benefit with an overall survival primary endpoint in NSCLC. Additionally, it is being broadly studied in combination with various immuno-oncology regimens that could boost the effects of PD-1 / PD-L1 antibodies.

For more "The Buzz" please visit: https://bit.ly/2Rlh4zH

About The Buzz: A Financial Buzz Show on daily news, covering the most up to date financial information. The Buzz intends to provide factual and relevant information for its audience. The Buzz is 100% original content, created by Financial Buzz Media. Located on Wall Street in the heart of New York City’s financial district, FinancialBuzz.com is a credible source for the world’s latest trending financial and economic news. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content.

© 2011 Financial Buzz. All rights reserved. No portion of this video or FinancialBuzz.com may be duplicated, redistributed or manipulated in any form without our consent, violators will be prosecuted to the full extent of the law.

FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the 'Site') is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. FinancialBuzz.com has not been compensated directly by any of the companies mentioned here in this editorial unless mentioned otherwise. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform.

Комментарии

Информация по комментариям в разработке

Похожие видео

  • О нас
  • Контакты
  • Отказ от ответственности - Disclaimer
  • Условия использования сайта - TOS
  • Политика конфиденциальности

video2dn Copyright © 2023 - 2025

Контакты для правообладателей [email protected]